Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 0/5 criteria met. Data as of 17/09/2026.
- ❌ Price trend failed
- ❌ Growth failed
- ❌ Debt failed
- ❌ P/E failed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: -24.04%
Price change 2019 → 2020: -6.37%
Price change 2020 → 2021: 67.64%
Price change 2021 → 2022: 16.54%
Price change 2022 → 2023: -14.73%
Price change 2023 → 2024: -24.27%
Price change 2024 → 2025: 6.46%
Price change 2025 → 2026: -22.15%
Price change 2026 (year to date): -27.14%
Financial growth
Revenue CAGR (8 years): -4.32%
Earnings CAGR (8 years): N/A
Growth status: insufficient data or negative trend.
Debt
Debt-to-equity ratio: 3.52
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -2.44
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 25.82% from the high over 6 months.
Excessive correction (> 20.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Eramet S.a. | – | 3.52 | −1.7 % | 🔒 |
| Imerys S.A. | – | 0.86 | +0.1 % | – |
| Vicat S.A. | 9.0 | 0.57 | +4.4 % | – |
| Arkema S.A. | 22.9 | 0.89 | +2.9 % | – |
| Vallourec S.A. | 9.1 | 0.40 | −1.1 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|